WithdrawnPhase 4

Role of Prophylactic Postoperative Antibiotics in HoLEP

Stopped: Lack of enrollment.

United States0Started 2023-03-01

Plain-language summary

The purpose of this study is to investigate whether prescribing a 3-day course of antibiotics after Holmium laser enucleation of the prostate (HoLEP) reduces the risk of urinary tract infection. The findings of this trial will have a major impact on clinical practice to either justify the prescription of antibiotics after HoLEP or give urologists more confidence in not prescribing antibiotics prophylactically after HoLEP.

Who can participate

Age range40 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men \> 40 years old with moderate to severe lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). * Patient with negative preoperative urine culture. Exclusion Criteria: * Patients with history of recurrent urinary tract infection or uro-sepsis. * Patient with preoperative infections * Patient with indwelling urethral catheter * Patient doing continuous intermitted catheterization (CIC)

What they're measuring

the rates of urinary tract infection within the 30-day post-operative period after HoLEP

Timeframe: within 30 days after HoLEP

Trial details

NCT IDNCT05274672

SponsorBaylor Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-20

View on ClinicalTrials.gov More Benign Prostatic Hyperplasia trials